These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36329790)

  • 1. The potential of miR-153 as aggressive prostate cancer biomarker.
    Gilyazova I; Ivanova E; Sinelnikov M; Pavlov V; Khusnutdinova E; Gareev I; Beilerli A; Mikhaleva L; Liang Y
    Noncoding RNA Res; 2023 Mar; 8(1):53-59. PubMed ID: 36329790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of miR-375 in prostate cancer: A study based on GEO, TCGA data and bioinformatics analysis.
    He S; Shi J; Mao J; Luo X; Liu W; Liu R; Yang F
    Pathol Res Pract; 2019 Jun; 215(6):152375. PubMed ID: 30879885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
    World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of microRNA-196b-5p in Hepatocellular Carcinoma and its Potential Molecular Mechanism.
    Zhang L; Luo B; Dang YW; He RQ; Peng ZG; Chen G; Feng ZB
    J Cancer; 2019; 10(22):5355-5370. PubMed ID: 31632480
    [No Abstract]   [Full Text] [Related]  

  • 5. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.
    Liang L; Zeng JH; Wang JY; He RQ; Ma J; Chen G; Cai XY; Hu XH
    Pathol Res Pract; 2017 Dec; 213(12):1494-1509. PubMed ID: 29113686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.
    He RQ; Yang X; Liang L; Chen G; Ma J
    Oncol Lett; 2018 Apr; 15(4):5517-5532. PubMed ID: 29552191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased oncogenic microRNA-18a expression in the peripheral blood of patients with prostate cancer: A potential novel non-invasive biomarker.
    Al-Kafaji G; Al-Naieb ZT; Bakhiet M
    Oncol Lett; 2016 Feb; 11(2):1201-1206. PubMed ID: 26893719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study.
    Huang WT; Wang HL; Yang H; Ren FH; Luo YH; Huang CQ; Liang YY; Liang HW; Chen G; Dang YW
    Onco Targets Ther; 2016; 9():5163-80. PubMed ID: 27578984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and target gene screening of hsa-miR-205 in lung squamous cell carcinoma.
    Huang W; Jin Y; Yuan Y; Bai C; Wu Y; Zhu H; Lu S
    Chin Med J (Engl); 2014; 127(2):272-8. PubMed ID: 24438615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between microRNA-125b expression in formalin-fixed paraffin-embedded tumor tissues and prognosis in patients with melanoma.
    Yan J; Jiang Q; Lu H; Na S; Long S; Xin Y; Zhang C; Zhang J
    Oncol Lett; 2019 Aug; 18(2):1856-1862. PubMed ID: 31423254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues.
    Liu Y; Ren F; Rong M; Luo Y; Dang Y; Chen G
    Cancer Cell Int; 2015; 15():62. PubMed ID: 26109910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
    Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
    BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy.
    Sun X; Liu Z; Yang Z; Xiao L; Wang F; He Y; Su P; Wang J; Jing B
    Diagn Pathol; 2013 Dec; 8():208. PubMed ID: 24350576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
    Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways.
    Wang SS; Fang YY; Huang JC; Liang YY; Guo YN; Pan LJ; Chen G
    Oncol Lett; 2019 Sep; 18(3):2939-2954. PubMed ID: 31402959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy.
    Guan Y; Wu Y; Liu Y; Ni J; Nong S
    Prostate; 2016 Aug; 76(11):986-93. PubMed ID: 27040772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Value of Circulating miR-324 for Prostate Cancer.
    Jin YY; Tong SQ; Tong M
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
    Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
    Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
    Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
    Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.